Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company, today announced that enrollment has been completed in the 1,000-patient post-marketing study required by the FDA.

Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company, today announced completion of the enrollment and treatment of patients in the ArteFill(R) Skin Test study. The Company reports that 498 study participants are enrolled in the study and have received ArteFill Skin Test injections.

The Board of Directors of Artes Medical, Inc.

Artes Medical (NASDAQ:ARTE) today announced the immediate availability of Elevess(TM), a new, FDA-approved hyaluronic acid (HA) based dermal filler for the treatment of facial wrinkles, such as nasolabial folds.

Artes Medical, Inc.